title: A consensus conference on complex biologics and low molecular weight heparins.
authors.affiliation: Under the auspices of the North American Thrombosis Forum (NATF), the International Union of Angiology (IUA) and the South Asian Society of Atherosclerosisand Thrombosis (SASAT). e.Kalodiki@imperial.ac.uk
authors.forename: E
authors.initials: E
authors.lastname: Kalodiki
authors.forename: J
authors.initials: J
authors.lastname: Fareed
authors.forename: V F
authors.initials: VF
authors.lastname: Tapson
authors.forename: D A
authors.initials: DA
authors.lastname: Hoppensteadt
authors.forename: I
authors.initials: I
authors.lastname: Sussman
authors.forename: C A
authors.initials: CA
authors.lastname: Carter
authors.forename: S
authors.initials: S
authors.lastname: Parker
authors.forename: J
authors.initials: J
authors.lastname: Harenberg
authors.forename: R
authors.initials: R
authors.lastname: Hull
authors.forename: G
authors.initials: G
authors.lastname: Rao
authors.forename: D F
authors.initials: DF
authors.lastname: Lovinger
authors.forename: L D
authors.initials: LD
authors.lastname: Ried
authors.forename: A
authors.initials: A
authors.lastname: Kakkar
authors.forename: L
authors.initials: L
authors.lastname: Talarico
authors.forename: F
authors.initials: F
authors.lastname: Ofuso
authors.forename: H I
authors.initials: HI
authors.lastname: Bussey
authors.forename: J
authors.initials: J
authors.lastname: Fanikos
authors.forename: J B
authors.initials: JB
authors.lastname: Groce
authors.forename: N
authors.initials: N
authors.lastname: Skinner
authors.forename: M
authors.initials: M
authors.lastname: Ahluwalia
authors.forename: O
authors.initials: O
authors.lastname: Iqbal
authors.forename: C M
authors.initials: CM
authors.lastname: Jackson
authors.forename: W P
authors.initials: WP
authors.lastname: Jeske
authors.forename: M
authors.initials: M
authors.lastname: Georges
authors.forename: E
authors.initials: E
authors.lastname: Ramacciotti
authors.forename: V F
authors.initials: VF
authors.lastname: Tapson
authors.forename: D
authors.initials: D
authors.lastname: Van Thiel
authors.forename: R
authors.initials: R
authors.lastname: Wahi
authors.forename: J
authors.initials: J
authors.lastname: Walenga
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001688:Biological Products / Q000009:adverse effects / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D003257:Consumer Product Safety; D017277:Drug Approval; D005060:Europe; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D009626:Terminology as Topic; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000925:Anticoagulants; D001688:Biological Products; D006495:Heparin, Low-Molecular-Weight